Calcium Hydroxylapatite Price

Ingredient: 26mg/ml HA, Hydroxyapatite 30%

Specification: 1ml

Package: Single package

Application Area: Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc.



Contact Now WhatsApp
Product Details

Product Introduction:

The product contains a high concentration of sodium hyaluronate, allowing it to achieve a firm and natural effect immediately after injection. Additionally, the hydroxyapatite used in the formulation has highly porous microspheres, which provide a larger specific surface area for interactions with fibroblasts. This enhances protein and cell adhesion, increasing the likelihood of self-growth factor enrichment.


Product Display:

Calcium Hydroxylapatite Price


Product Details:

Type

CaHA Filler

Ingredient

Hyaluronic 26mg/ml, hydroxyapatite 30%

Specification

1ml

Effect area

Subcutaneous injection

Application area

Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc

How to choose

Moderate to severe naso-lip wrinkles

Package

Single package

Storage

Cool, dry environment

Recommended
Use quantity

1-2 pc/time

Recommended interval

12-24 months

Lasting time

18-24 months

Microsphere size

25-45μm

Extruding force

23N (27G thin-walled needle)


Product Package:

Calcium Hydroxylapatite Price


Customer Feedback:

Customer Feedback

Customer Feedback


Raw Material Advantages:

1. Sodium hyaluronate penetrates deep into the dermis, instantly revitalizing the skin and delivering an immediate firming and lifting effect. Hydroxyapatite stimulates collagen fiber production, effectively repairing the skin’s internal structure and supporting natural collagen regeneration. Over time, a dense and refined collagen network forms within the skin, ensuring a long-lasting lifting effect.

2. The FDA-approved Radiesse microcrystal filler is recognized as an ideal semi-solid, non-surgical facial filler. Currently, no “hydroxyapatite microsphere facial filler” products have been approved by the National Medical Products Administration (NMPA) in China.


Development Process:

Development Process


Company Introduction:

The synthesis of PCL/PLLA on our platform is characterized by low tin content (Sn <30 ppm), controlled molecular weight, and compliance with medical-grade biocompatibility standards, utilizing custom-designed synthesis equipment that operates under anhydrous, oxygen-free conditions for kilogram-scale production. Moreover, our purification technology transforms industrial-grade raw materials into sterile, pyrogen-free medical-grade substances, such as sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.

Leave your messages

Related Products

x

Popular products

x